tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Is DRUG a Buy, Before Earnings?
Pre-EarningsIs DRUG a Buy, Before Earnings?
5h ago
DRUG
Bright Minds Biosciences Strengthens Advisory Board with PWS Experts
PremiumCompany Announcements
Bright Minds Biosciences Strengthens Advisory Board with PWS Experts
29d ago
DRUG
Bright Minds Biosciences: Strategic Advancements in Serotonergic Therapies and Expansion into Prader-Willi Syndrome
PremiumRatings
Bright Minds Biosciences: Strategic Advancements in Serotonergic Therapies and Expansion into Prader-Willi Syndrome
1M ago
DRUG
Bright Minds Biosciences Launches New Prader-Willi Syndrome Program
PremiumCompany Announcements
Bright Minds Biosciences Launches New Prader-Willi Syndrome Program
1M ago
DRUG
Bright Minds Biosciences to Present at Key Healthcare Conferences and Grants Equity Incentives
PremiumCompany Announcements
Bright Minds Biosciences to Present at Key Healthcare Conferences and Grants Equity Incentives
1M ago
DRUG
Bright Minds price target raised to $82 from $75 at Baird
PremiumThe FlyBright Minds price target raised to $82 from $75 at Baird
1M ago
DRUG
Psychedelic: Compass Pathways, GH Research report Q3 earnings
Premium
The Fly
Psychedelic: Compass Pathways, GH Research report Q3 earnings
1M ago
PBM
ATAI
Bright Minds Biosciences Advances Epilepsy Treatment with BMB-101 Study
Premium
Company Announcements
Bright Minds Biosciences Advances Epilepsy Treatment with BMB-101 Study
2M ago
DRUG
Bright Minds Biosciences’ Promising Pipeline and Strategic Expansion Justify Buy Rating
PremiumRatings
Bright Minds Biosciences’ Promising Pipeline and Strategic Expansion Justify Buy Rating
3M ago
DRUG
Psychedelic: Cybin completes enrollment in CYB004 Phase 2 study
PremiumThe Fly
Psychedelic: Cybin completes enrollment in CYB004 Phase 2 study
3M ago
CYBN
DRUG
Bright Minds initiated with a Buy at BTIG
PremiumThe Fly
Bright Minds initiated with a Buy at BTIG
3M ago
DRUG
Bright Minds Biosciences Launches $100 Million At-The-Market Offering
PremiumCompany Announcements
Bright Minds Biosciences Launches $100 Million At-The-Market Offering
3M ago
DRUG
Psychedelic: Bright Minds reports preclinical BMB-201 results
PremiumThe FlyPsychedelic: Bright Minds reports preclinical BMB-201 results
3M ago
CMPS
CYBN
Bright Minds says BMB-201 outperforms sumatriptan in preclinical model
Premium
The Fly
Bright Minds says BMB-201 outperforms sumatriptan in preclinical model
3M ago
DRUG
Bright Minds Biosciences: Advancing Breakthrough Epilepsy Treatment with BMB-101 and Strong Financial Position
Premium
Ratings
Bright Minds Biosciences: Advancing Breakthrough Epilepsy Treatment with BMB-101 and Strong Financial Position
4M ago
DRUG
Bright Minds Biosciences Reports Q3 2025 Financial Results
PremiumCompany Announcements
Bright Minds Biosciences Reports Q3 2025 Financial Results
4M ago
6K
DRUG
Psychedelic: atai Life Sciences, Cybin report earnings results
PremiumThe Fly
Psychedelic: atai Life Sciences, Cybin report earnings results
4M ago
ATAI
CYBN
Psychedelic: atai Life Sciences, Beckley Psytech report BPL-003 study results
PremiumThe Fly
Psychedelic: atai Life Sciences, Beckley Psytech report BPL-003 study results
6M ago
ATAI
CMND
Bright Minds assumed with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Bright Minds assumed with an Overweight at Cantor Fitzgerald
6M ago
DRUG
Bright Minds Biosciences to Present at 2025 Jefferies Global Healthcare Conference
PremiumCompany AnnouncementsBright Minds Biosciences to Present at 2025 Jefferies Global Healthcare Conference
7M ago
DRUG
Bright Minds Biosciences’ BMB-101: A Promising Breakthrough in Treatment-Resistant Epilepsy
Premium
Ratings
Bright Minds Biosciences’ BMB-101: A Promising Breakthrough in Treatment-Resistant Epilepsy
7M ago
DRUG
Bright Minds Biosciences: Buy Rating Issued on Promising Potential of BMB-101 for Absence Seizures
Premium
Ratings
Bright Minds Biosciences: Buy Rating Issued on Promising Potential of BMB-101 for Absence Seizures
7M ago
DRUG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >